Prestige Consumer Healthcare logo

Prestige Consumer Healthcare

PBH | NYSE
Chart Builder DCF Calculator
$48.00
+$1.81 (+3.92%)
At close: Nov 16, 2026, 4:00 PM ET
$48.00
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:00 PM ET
+3.92%

Rating

Updated: Nov 16, 2026
50.1
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #284/1021 (Top 28%)

Key Statistics

Market Data

Market Cap $2.28B
1D Range
46.70 48.28
52W Range
42.98 70.21

Valuation (TTM)

PE 14.81
PB 1.17
EV/EBITDA 13.80

Valuation (NTM)

Forward PE 10.24
Forward PEG -21.44
Price Target $51.00
Loading financial charts...

Profile

Prestige Consumer Healthcare Inc., along with its various divisions, is involved in the creation, production, promotion, and distribution of non-prescription health and personal care items across both...

Sector Healthcare
Employees 890
IPO Date Feb 10, 2005
Fiscal Year April - March

Latest News

What Premium Brands (PBH) Said on Its Q3 Earnings Call

9 days ago · marketbeat.com

What Premium Brands (PBH) Said on Its Q3 Earnings Call
Prestige Consumer Healthcare Q2 Earnings Call Highlights

9 days ago · marketbeat.com

Prestige Consumer Healthcare Q2 Earnings Call Highlights
Prestige Consumer Healthcare Inc. (PBH) Q2 2027 Earnings Call Transcript

9 days ago · seekingalpha.com

Prestige Consumer Healthcare Inc. (PBH) Q2 2027 Earnings Call Transcript
Compared to Estimates, Prestige Consumer Healthcare (PBH) Q2 Earnings: A Look at Key Metrics

12 days ago · zacks.com

Compared to Estimates, Prestige Consumer Healthcare (PBH) Q2 Earnings: A Look at Key Metrics
Prestige Consumer Healthcare Inc. Reports Fiscal 2027 Second Quarter Results

12 days ago · globenewswire.com

Prestige Consumer Healthcare Inc. Reports Fiscal 2027 Second Quarter Results
Amylyx Pharmaceuticals to Host Investor Event at ObesityWeek® 2026 Featuring Leading PBH Experts

13 days ago · businesswire.com

Amylyx Pharmaceuticals to Host Investor Event at ObesityWeek® 2026 Featuring Leading PBH Experts
Prestige Consumer Healthcare Inc (PBH) Shares Fall 3.4% -- What GF Score of 70 Tells Investors

24 days ago · gurufocus.com

Prestige Consumer Healthcare Inc (PBH) Shares Fall 3.4% -- What GF Score of 70 Tells Investors
Is it Apt to Retain Prestige Consumer Stock in Your Portfolio Now?

1 month ago · zacks.com

Is it Apt to Retain Prestige Consumer Stock in Your Portfolio Now?
Prestige Consumer Healthcare to Release Fiscal 2027 Second Quarter Earnings Results

1 month ago · globenewswire.com

Prestige Consumer Healthcare to Release Fiscal 2027 Second Quarter Earnings Results
Amylyx's Avexitide Phase III Win Sets Up FDA Filing for PBH Treatment

2 months ago · marketbeat.com

Amylyx's Avexitide Phase III Win Sets Up FDA Filing for PBH Treatment

Earnings

Latest Earnings
Nov 5, 2026
EPS
$1.13
Beat +5.61%
REV
$336.31M
Beat +2.18%
Next Earnings
Feb 4, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
3
Consensus
Hold
Price Target
$51.00
Upside
+6.25%
Buy (1)
Hold (2)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.